The Patent Finder

Crown Bioscience, Inc. (Taicang)

Also on record
Records under this name other than the patents Crown Bioscience, Inc. (Taicang) holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Showing 1 to 3 of 3 · Back to Crown Bioscience, Inc. (Taicang)

PatentTitleStatus Expires Confidence
US 9,695,175Highly selective c-Met inhibitors as anticancer agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,020,494Animal Models for Nonalcoholic Fatty Liver Disease
Formerly held
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 9,921,222Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-EGFR drug
Lapsed on the fee record
Ended Mar 20, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 20, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited